领先 发表于 2025-4-1 04:47:18

http://reply.papertrans.cn/43/4209/420812/420812_61.png

新奇 发表于 2025-4-1 09:22:02

http://reply.papertrans.cn/43/4209/420812/420812_62.png

Canopy 发表于 2025-4-1 10:47:09

Donald E. Thomas,Philip R. Moorbys chapter focuses on the most up-to-date clinical trials involving pharmacogenomics and anticancer therapy. A brief introduction of drug development and the difference between somatic and germline DNA mutations sets up the chapter for understanding the progress which has been made in regard to indiv

FELON 发表于 2025-4-1 18:07:11

http://reply.papertrans.cn/43/4209/420812/420812_64.png

CERE 发表于 2025-4-1 22:00:01

http://reply.papertrans.cn/43/4209/420812/420812_65.png

Liberate 发表于 2025-4-2 00:16:14

,Verilog – A Tutorial Introduction,e excision repair (NER) pathway is the mammalian DNA repair mechanism that removes bulky DNA adducts induced by DNA damaging chemotherapeutic agents. Platinum compounds induce their cytotoxic effect by binding to a DNA molecule in the form of a platinum-DNA-adduct. The NER pathway is the main mechan
页: 1 2 3 4 5 6 [7]
查看完整版本: Titlebook: Handbook of Anticancer Pharmacokinetics and Pharmacodynamics; Michelle A. Rudek,Cindy H. Chau,Howard L. McLeod Book 2014Latest edition Spr